FDA approves new treatment for a rare genetic disorder, Fabry disease
FDA approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease.
-
Subscribe
Subscribe via the RSS feed
FDA approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease.